Hyun Min Kim, Joonyeop Lee, Seokjin Kim, Jong Wook Lee, Hee-Je Kim, Young-Seok Cho
{"title":"Fecal microbiota transplantation for steroid-refractory gastrointestinal graft-versus-host disease.","authors":"Hyun Min Kim, Joonyeop Lee, Seokjin Kim, Jong Wook Lee, Hee-Je Kim, Young-Seok Cho","doi":"10.5045/br.2023.2023069","DOIUrl":null,"url":null,"abstract":"2 AML (MSD) TBI (1320 cGy), CpS 60 mg/kg (2 days) 2 ATG MTX CsA MMF Ruxolitinib +140 Unrelated 1 colonoscopy C.difficile: negative Comorbid infection: CMV viremia +33 bacteremia (VSE) No response, died from hepatic GVHD and sepsis on day +174 3 Relapsed MM (MUD) Fludarabine 30 mg/m (5 days) 3 ATG MTX MMF FK +44 Unrelated 4 colonoscopy C.difficile: negative Comorbid infection: CMV viremia +10 after 1 FMT: infectious colitis +14 after 4 FMT: CMV colitis Partial response after ruxolitinib add on","PeriodicalId":46224,"journal":{"name":"Blood Research","volume":null,"pages":null},"PeriodicalIF":2.3000,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/df/40/br-58-3-145.PMC10548292.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Blood Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5045/br.2023.2023069","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/7/11 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
2 AML (MSD) TBI (1320 cGy), CpS 60 mg/kg (2 days) 2 ATG MTX CsA MMF Ruxolitinib +140 Unrelated 1 colonoscopy C.difficile: negative Comorbid infection: CMV viremia +33 bacteremia (VSE) No response, died from hepatic GVHD and sepsis on day +174 3 Relapsed MM (MUD) Fludarabine 30 mg/m (5 days) 3 ATG MTX MMF FK +44 Unrelated 4 colonoscopy C.difficile: negative Comorbid infection: CMV viremia +10 after 1 FMT: infectious colitis +14 after 4 FMT: CMV colitis Partial response after ruxolitinib add on